IQVIA艾昆纬：2025年艾滋病支出趋势-持续的艾滋病患者护理和创新报告（英文版）

Over the past four decades, HIV treatment and prevention have advanced dramatically through effective antiretroviral therapies (ART) and pre-exposure prophylaxis (PrEP), transforming HIV into a manageable chronic condition. In 2024, 40.8 million people were living with HIV, with 31.6 million receiving ART.Despite this progress, unmet needs persist—especially for vulnerable populations facing stigma, fragmented care, and adherence challenges. Drug resistance remains a global concern, underscor